1Zentrums Innere Medizin und Dermatologie, Medizinischen Hochschule Hannover.
Interferon therapy can improve hepatitis B e-antigen (HBeAg) seroconversion in chronic hepatitis B patients. However, its effectiveness may be limited by the virus's nuclear DNA, hindering interferon's antiviral activity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: